RANZCP homepage
Clinical guidelines & publications library
-
Proposal to Amend Prescriber Regulations for Stimulant Medications
ADHD
RANZCP NZ Submission to PHARMAC regarding the Proposal to Amend Prescriber Regulations for Stimulant Medications
Submission- Last updated: Feb 2025
- Published in New Zealand
- 25NZ
-
Government's Response to the Senate Inquiry on ADHD
ADHD
RANZCP submission to the Minister for Health and Aged Care regarding the Government's Response to the Senate Inquiry on ADHD PDF Submission
Submission- Last updated: Jan 2025
- Published in Australia
- 17AUS
-
Queensland Health Consultation – Psychostimulant Prescribing Authorisations
ADHD
RANZCP QLD Branch Submission to Queensland Health regarding the Queensland Health Consultation – Psychostimulant Prescribing Authorisations PDF Submission
Submission- Last updated: Dec 2024
- Published in Queensland
- 05QLD
-
Proposal to Remove the Renewal Criteria for Stimulant Treatments
ADHD, Professionalism
RANZCP NZ Submission to Pharmac regarding the Proposal to Remove the Renewal Criteria for Stimulant Treatments
Submission- Last updated: Sep 2024
- Published in New Zealand
- 12NZ
-
Proposal to Fund Lisdexamfetamine for Attention Deficit Hyperactivity Disorder
ADHD
RANZCP NZ Submission to Pharmac regarding the Proposal to Fund Lisdexamfetamine for Attention Deficit Hyperactivity Disorder
Submission- Last updated: Sep 2024
- Published in New Zealand
- 13NZ
-
Inquiry into the Assessment and Treatment of ADHD and Support Services
ADHD
RANZCP Tasmania Branch Submission to Tasmanian Parliament regarding the Inquiry into the Assessment and Treatment of ADHD and Support Services. PDF Submission
Submission- Last updated: Aug 2024
- Published in Tasmania
- 01TAS
-
Adult attention deficit hyperactivity disorder (ADHD) practice guidelines
ADHD, Professionalism
This guideline was rescinded in April 2024.
Clinical guideline- Last updated: Apr 2024
- Published in Australia
- Rescinded
-
Consultation on methylphenidate to include early access to the Ritalin LA preparations
ADHD
Submission to Pharmac regarding consultation on methylphenidate to include early access to the Ritalin LA preparations. PDF Submission
Submission- Last updated: Jun 2023
- Published in New Zealand
- Current
-
Consultation on the special authority criteria for the class B stimulants
ADHD
Submission to Pharmac regarding the special authority criteria for the class B stimulants prescriptions in Aotearoa.
PDF SubmissionSubmission- Last updated: Jun 2023
- Published in New Zealand
- Current
-
ADHD across the lifespan
ADHD, Professionalism
Attention Deficit Hyperactivity Disorder (ADHD) is a major mental disorder. This statement presents principles to develop a more appropriate, accessible, equitable health system that caters for the needs of people with ADHD across their lifespan.
Position statement- Last updated: Mar 2023
- Published in Australia
- PS #55
